Table 2.

Comparison of the level of evidence

	2015 N = 15	2016 N = 32	2017 N = 46	2018 N = 76	2019 N = 102	2020 N = 40
Lower level of evidence of real treatment option (n, %)	4  (26.7)	8  (25.0)	6  (13.0)	19 (25.0)	11 (10.8)	3  (7.5)
Difference in SVR% (among patients with same level of evidence) (median, range)	3 (3–6)	2 (1–6)	3 (1–4)	1 (1–3)	1 (1–3)	1 (1–2.5)

Comparison of the level of evidence between real treatment regimen and preferred treatment option according to the HCV TS, among patients that received another treatment regimen than the preferred treatment options according to the HCV TS

SVR Sustained virological response, HCV TS Hepatitis C Therapy Selector